CD83 is a new potential biomarker and therapeutic target for lymphoma

被引：0
|
作者：
Ju, X. [1 ]
Li, Z. [1 ]
Abadir, E. [1 ]
Lee, K. [2 ]
Clarke, C. [2 ]
Hsu, J. [1 ]
Bryant, C. [1 ]
Pears, S. [3 ]
Sunderland, N. [3 ]
Heffernan, S. [3 ]
Hennessy, A. [3 ]
Lo, T. H. [1 ]
Pietersz, G. [4 ]
Fromm, P. [1 ]
Silveira, P. [1 ]
Tsonis, C. [1 ]
Cooper, W. [5 ]
Cunningham, I. [6 ]
Brown, C. [7 ]
Clark, G. [1 ]
Hart, D. [1 ]
机构：
[1] ANZAC Res Inst, Dendrit Cell Res, Sydney, NSW, Australia
[2] Concord Repatriat Gen Hosp, Dept Anat Pathol, Sydney, NSW, Australia
[3] Royal Prince Alfred Hosp, Anim Facil, Sydney, NSW, Australia
[4] Burnet Inst, Melbourne, Vic, Australia
[5] Royal Prince Alfred Hosp, Tissue Pathol & Diagnost Oncol, Sydney, NSW, Australia
[6] Concord Repatriat Gen Hosp, Dept Haemtol, Sydney, NSW, Australia
[7] Royal Prince Alfred Hosp, Inst Haematol, Sydney, NSW, Australia
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P1677
引用
收藏
页码：1679 / 1679
页数：1
相关论文
共 50 条
  • [1] CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
    Li, Ziduo
    Ju, Xinsheng
    Lee, Kenneth
    Clarke, Candice
    Hsu, Jennifer L.
    Abadir, Edward
    Bryant, Christian E.
    Pears, Suzanne
    Sunderland, Neroli
    Heffernan, Scott
    Hennessy, Annemarie
    Lo, Tsun-Ho
    Pietersz, Geoffrey A.
    Kupresanin, Fiona
    Fromm, Phillip D.
    Silveira, Pablo A.
    Tsonis, Con
    Cooper, Wendy A.
    Cunningham, Ilona
    Brown, Christina
    Clark, Georgina J.
    Hart, Derek N. J.
    HAEMATOLOGICA, 2018, 103 (04) : 655 - 665
  • [2] CD83 antigen: A potential new target for immunosuppression.
    Munster, DJ
    Kato, M
    MacDonald, KPA
    Hart, D
    BLOOD, 2002, 100 (11) : 57B - 57B
  • [3] CD83 in Hodgkin lymphoma
    Kueppers, Ralf
    HAEMATOLOGICA, 2018, 103 (04) : 561 - 562
  • [4] Dendritic cell CD83: A therapeutic target or innocent bystander?
    Prazma, Charlene M.
    Tedder, Thomas F.
    IMMUNOLOGY LETTERS, 2008, 115 (01) : 1 - 8
  • [5] Targeting CD83 in mantle cell lymphoma with anti-human CD83 antibody
    Li, Ziduo
    Abadir, Edward
    Lee, Kenneth
    Clarke, Candice
    Bryant, Christian E.
    Cooper, Wendy
    Pietersz, Geoffrey
    Favaloro, James
    Silveira, Pablo A.
    NJ Hart, Derek
    Ju, Xinsheng
    Clark, Georgina J.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2020, 9 (07)
  • [6] CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
    Li, Ziduo
    Ju, Xinsheng
    Silveira, Pablo A.
    Abadir, Edward
    Hsu, Wei-Hsun
    Hart, Derek N. J.
    Clark, Georgina J.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [7] CD83 as a Theranostic Target for Acute Myeloid Leukemia
    Ott, K.
    Robertson, A. J.
    Gallant, J. P.
    Walton, K. K.
    Betts, B. C.
    LeBeau, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S280 - S280
  • [8] Orthologs of CD83
    Hansen, JD
    Flajnik, MF
    Ohta, Y
    FASEB JOURNAL, 2004, 18 (04): : A426 - A426
  • [9] CD83 EXPRESSION ON HUMAN IMMUNE CELLS AS A TARGET FOR IMMUNOSUPPRESSION
    Hart, D. N. J.
    Elgundi, Z.
    Ju Xinsheng
    Verma, N. D.
    Silveira, P. A.
    Fromm, P. D.
    Alingcastre, R.
    Munster, D. J.
    Seldon, T. A.
    Sheng, Y.
    Jones, M. L.
    Munro, T. P.
    Mahler, S.
    Barnard, R. T.
    Vu, P. A.
    Lo, K.
    Shahin, K.
    Larsen, S.
    Bradstock, K.
    Clark, G. J.
    IMMUNOLOGY AND CELL BIOLOGY, 2015, 93 (09): : A8 - A8
  • [10] Construction of a mouse CD83 tetramer to define CD83's role in T cell development
    Ma, X
    Sant'Angelo, DB
    FASEB JOURNAL, 2003, 17 (07): : C149 - C149
12345